Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $155,998 | $157,026 | $115,131 | $118,372 |
| - Cash | $25,169 | $22,894 | $368 | $247 |
| + Debt | $1,280 | $1,340 | $1,490 | $1,640 |
| Enterprise Value | $132,109 | $135,472 | $116,253 | $119,765 |
| Revenue | $88,330 | $75,579 | $67,493 | $65,381 |
| % Growth | 16.9% | 12% | 3.2% | – |
| Gross Profit | $44,065 | $37,341 | $224 | $238 |
| % Margin | 49.9% | 49.4% | 0.3% | 0.4% |
| EBITDA | $20,246 | $18,721 | $2,966 | $2,328 |
| % Margin | 22.9% | 24.8% | 4.4% | 3.6% |
| Net Income | $11,961 | $11,160 | $10,528 | $12,921 |
| % Margin | 13.5% | 14.8% | 15.6% | 19.8% |
| EPS Diluted | 274.21 | 246.58 | 228.31 | 280.2 |
| % Growth | 11.2% | 8% | -18.5% | – |
| Operating Cash Flow | $6,521 | -$1,677 | -$50 | $13 |
| Capital Expenditures | -$5,030 | -$1,833 | -$54 | -$47 |
| Free Cash Flow | $1,491 | -$3,510 | -$105 | -$34 |